Adamski, V., Hempelmann, A., Flüh, C., Lucius, R., Synowitz, M., Hattermann, K., & Held-Feindt, J. (2017). Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment. Oncotarget.

Adamski, Vivian, Annika Hempelmann, Charlotte Flüh, Ralph Lucius, Michael Synowitz, Kirsten Hattermann, and Janka Held-Feindt. "Dormant Glioblastoma Cells Acquire Stem Cell Characteristics and Are Differentially Affected By Temozolomide and AT101 Treatment." Oncotarget 2017.

Adamski, Vivian, et al. "Dormant Glioblastoma Cells Acquire Stem Cell Characteristics and Are Differentially Affected By Temozolomide and AT101 Treatment." Oncotarget 2017.